Category: Latest News
-
Oil prices cautious as U.S. inventory data and Trump-Putin meeting loom
Oil hovered near two-month lows in Asian trading on Wednesday as investors braced for a high-stakes meeting between U.S. President Donald Trump and Russian President Vladimir Putin scheduled for later this week. Markets also focused on U.S. crude stockpiles after industry data revealed a surprising rise in inventories in the world’s largest oil consumer. Crude…
-
Dollar Slides as Investors Anticipate Fed Rate Cut in September
The U.S. dollar retreated on Wednesday, continuing its downward trend after modest inflation data fueled speculation that the Federal Reserve may lower interest rates next month. By 04:25 ET (08:25 GMT), the Dollar Index, which measures the currency against six major peers, fell 0.4% to 97.540, following a 0.5% drop in the previous session. September…
-
Dow Jones, S&P, Nasdaq, Wall Street, U.S. Futures Climb, Cisco Reports Incoming, Ether Approaches Record Levels
U.S. stock futures rose Wednesday, signaling a likely continuation of Wall Street’s gains after soft inflation data pushed the S&P 500 and Nasdaq Composite to all-time closing highs. Cisco Systems (NASDAQ:CSCO) is scheduled to report earnings, with analysts watching closely for its fiscal 2026 outlook. Meanwhile, Perplexity AI has made a $34.5 billion bid to…
-
CoreWeave Posts Larger-Than-Expected Q2 Loss Amid Rising Costs
Shares of CoreWeave (NASDAQ:CRWV) dropped over 10% in premarket U.S. trading on Wednesday after the cloud computing company reported second-quarter results showing revenue above expectations due to strong AI-driven demand, but losses significantly exceeded forecasts as expenses surged. For the quarter ending June 30, CoreWeave posted a loss of $0.60 per share on $1.21 billion…
-
Perplexity AI Makes $34.5 Billion Bid for Google’s Chrome Amid Antitrust Scrutiny
AI startup Perplexity AI has put forward an unsolicited $34.5 billion offer to acquire Google’s Chrome browser, anticipating potential regulatory requirements arising from the search giant’s ongoing antitrust case in the U.S. The bid, submitted Tuesday morning (12), comes at a moment of uncertainty for Google, following a court ruling that identified the company’s monopoly…
-
Cava Shares Plunge Premarket After Company Cuts Full-Year Sales Guidance
Cava (NYSE:CAVA) saw its shares drop 22% in premarket trading in the U.S. following a reduction in its annual restaurant sales forecast. The Mediterranean-focused chain reported quarterly earnings of $0.16 per share for the period ending in June, above analysts’ consensus of $0.13 per share. Revenue climbed 20% year-over-year to $280.6 million, slightly below expectations…
-
Nasdaq, S&P 500 Rally To New Record Highs Following Inflation Data
After ending Monday’s choppy trading session moderately lower, stocks showed a strong move back to the upside during trading on Tuesday. The major averages more than offset the losses posted in the previous session, with the Nasdaq and the S&P 500 reaching new record closing highs. The major averages ended the session near their best…
-
Musk and Altman Clash Again as AI Leaders Accuse Each Other of Platform Manipulation
The ongoing public feud between tech CEOs Elon Musk and Sam Altman flared up once more Tuesday, as both exchanged sharp accusations over alleged algorithmic manipulation on their platforms. The conflict reignited Monday when Musk accused Apple (NASDAQ:AAPL) of favoring OpenAI’s ChatGPT over his own AI chatbot Grok on the App Store, branding it an…
-
Amphastar Shares Climb on Exclusive Licensing Deal for Three Peptide Therapies
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock rise 5.6% after securing an exclusive licensing agreement with Nanjing Anji Biotechnology for three proprietary peptide-based therapies aimed at oncology and ophthalmology markets. Under the deal, Amphastar gains exclusive rights to develop, produce, and market the therapies in the United States and Canada. The first candidate is an endogenous…
-
180 Life Sciences Stock Surges 75% Following Disclosure of Large Ethereum Holdings
180 Life Sciences Corp. (NASDAQ:ATNF), now operating under the name ETHZilla, experienced a sharp 75% increase in its stock price after announcing it holds 82,186 Ethereum tokens valued at roughly $349 million. The company revealed it acquired this sizable ETH position at an average cost of $3,806.71 per token. Alongside its cryptocurrency assets, ETHZilla also…